In an analysis of more than 4,000 women with ovarian cancer, it appears that some hormonal and reproductive factors may affect tumor aggressiveness. The study showed that increased age was … Continued
A study of 149 women with platinum sensitive ovarian cancer, half treated with carboplatin and paclitaxel or gemcitabine, half with that treatment plus pertuzumab, showed that the addition of pertuzumab … Continued
OCRF receives record number of research grant applications; launches national patient support program with new educational grants New York, NY January 10, 2013 — Ovarian Cancer Research Fund (OCRF) has … Continued
OCRF has awarded nearly $6 million in grants for ovarian cancer research this year. After receiving over 170 applications – the highest number in its history, for the second year … Continued
1/09/2013 Analyzing DNA from Pap smears could help detect endometrial and ovarian cancer, a new study published Jan. 9, 2013 in Science Translational Medicine reports. OCRF Scientific Advisory Committee member (and former … Continued
1/3/2013 In the most recent edition of the Journal of Clinical Oncology, researchers in the UK published preliminary results from the United Kingdom Familial Ovarian Cancer Screen Study, a large trial testing … Continued
01/01/2013 Previous studies have suggested that BRCA mutation carriers with ovarian cancer have better survival rates than women who are not carriers. Researchers in Canada and the US sought to investigate … Continued
12/11/12 | In 2012, hardworking, dedicated OCRF scientists made significant advances in the fight against ovarian cancer. Below is just a sample of some of the exciting discoveries made by … Continued
Metformin, a drug used to treat diabetes and polycystic ovarian syndrome (PCOS), may increase survival for women with ovarian cancer. A study of 239 women with ovarian cancer divided them … Continued
Ivan Garcia-Bassets, Ph.D., a 2012 OCRF Grantee, changed his research focus to ovarian cancer after his wife received a devastating diagnosis.
A study by the Commonwealth Foundation found that patients with expensive treatment, such as palliative chemotherapy, were more likely to be turned away from hospice facilities. Some findings include The … Continued
12/03/2012 Researchers at the Mayo Clinic have shown that ovarian cancer patients who were taking the common diabetes drug metformin survived longer than patients who weren’t on the drug. The research was … Continued
Get email updates about research news, action alerts, and ways to join the fight.
